CAH
Price
$161.02
Change
-$0.67 (-0.41%)
Updated
Jul 15 closing price
Capitalization
27.26B
22 days until earnings call
MCK
Price
$715.67
Change
+$4.85 (+0.68%)
Updated
Jul 16, 04:59 PM (EDT)
Capitalization
70.55B
21 days until earnings call
Interact to see
Advertisement

CAH vs MCK

Header iconCAH vs MCK Comparison
Open Charts CAH vs MCKBanner chart's image
Cardinal Health
Price$161.02
Change-$0.67 (-0.41%)
Volume$1.92M
Capitalization27.26B
McKesson
Price$715.67
Change+$4.85 (+0.68%)
Volume$3.3K
Capitalization70.55B
CAH vs MCK Comparison Chart in %
Loading...
CAH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MCK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CAH vs. MCK commentary
Jul 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAH is a StrongBuy and MCK is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 17, 2025
Stock price -- (CAH: $161.02 vs. MCK: $710.82)
Brand notoriety: CAH: Not notable vs. MCK: Notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: CAH: 96% vs. MCK: 51%
Market capitalization -- CAH: $27.26B vs. MCK: $70.55B
CAH [@Medical Distributors] is valued at $27.26B. MCK’s [@Medical Distributors] market capitalization is $70.55B. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Distributors] industry is $10.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CAH’s FA Score shows that 2 FA rating(s) are green whileMCK’s FA Score has 1 green FA rating(s).

  • CAH’s FA Score: 2 green, 3 red.
  • MCK’s FA Score: 1 green, 4 red.
According to our system of comparison, both CAH and MCK are a good buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CAH’s TA Score shows that 3 TA indicator(s) are bullish while MCK’s TA Score has 4 bullish TA indicator(s).

  • CAH’s TA Score: 3 bullish, 5 bearish.
  • MCK’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, MCK is a better buy in the short-term than CAH.

Price Growth

CAH (@Medical Distributors) experienced а -2.09% price change this week, while MCK (@Medical Distributors) price change was -1.84% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was -0.02%. For the same industry, the average monthly price growth was +6.66%, and the average quarterly price growth was +0.90%.

Reported Earning Dates

CAH is expected to report earnings on Oct 31, 2025.

MCK is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Medical Distributors (-0.02% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MCK($70.5B) has a higher market cap than CAH($27.3B). CAH has higher P/E ratio than MCK: CAH (44.47) vs MCK (24.25). CAH YTD gains are higher at: 37.653 vs. MCK (24.987). MCK has higher annual earnings (EBITDA): 4.44B vs. CAH (1.89B). CAH has more cash in the bank: 4.59B vs. MCK (1.98B). CAH has less debt than MCK: CAH (4.72B) vs MCK (7.61B). MCK has higher revenues than CAH: MCK (302B) vs CAH (216B).
CAHMCKCAH / MCK
Capitalization27.3B70.5B39%
EBITDA1.89B4.44B43%
Gain YTD37.65324.987151%
P/E Ratio44.4724.25183%
Revenue216B302B72%
Total Cash4.59B1.98B232%
Total Debt4.72B7.61B62%
FUNDAMENTALS RATINGS
CAH vs MCK: Fundamental Ratings
CAH
MCK
OUTLOOK RATING
1..100
7518
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
25
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
950
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CAH's Valuation (50) in the Medical Distributors industry is in the same range as MCK (50). This means that CAH’s stock grew similarly to MCK’s over the last 12 months.

CAH's Profit vs Risk Rating (2) in the Medical Distributors industry is in the same range as MCK (5). This means that CAH’s stock grew similarly to MCK’s over the last 12 months.

CAH's SMR Rating (100) in the Medical Distributors industry is in the same range as MCK (100). This means that CAH’s stock grew similarly to MCK’s over the last 12 months.

CAH's Price Growth Rating (9) in the Medical Distributors industry is somewhat better than the same rating for MCK (50). This means that CAH’s stock grew somewhat faster than MCK’s over the last 12 months.

CAH's P/E Growth Rating (100) in the Medical Distributors industry is in the same range as MCK (100). This means that CAH’s stock grew similarly to MCK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CAHMCK
RSI
ODDS (%)
Bearish Trend 2 days ago
59%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
47%
Bearish Trend 2 days ago
46%
MACD
ODDS (%)
Bearish Trend 2 days ago
45%
Bearish Trend 2 days ago
42%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
45%
Bearish Trend 2 days ago
38%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
59%
Bearish Trend 2 days ago
38%
Advances
ODDS (%)
Bullish Trend 20 days ago
67%
Bullish Trend 10 days ago
66%
Declines
ODDS (%)
Bearish Trend 6 days ago
46%
Bearish Trend 6 days ago
39%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
56%
Bullish Trend 2 days ago
68%
Aroon
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
CAH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MCK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EWT58.270.46
+0.80%
iShares MSCI Taiwan ETF
QTAP42.260.01
+0.03%
Innovator Growth-100 Acltd Ps ETF™ April
WXET19.54N/A
N/A
Teucrium 2x Daily Wheat ETF
XSVN46.98-0.19
-0.41%
BondBloxx Bloomberg SevenYrTrgDurUSTrETF
GII66.38-0.85
-1.26%
SPDR® S&P® Global Infrastructure ETF